• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单点前列腺活检在高度怀疑前列腺癌老年患者中的应用。

Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer.

作者信息

Luan Yang, Xiao Qin, Ding Xue-Fei, Zhu Liang-Yong, Han Yue-Xing, Chen Hao-Peng, Huang Tian-Bao, Lu Sheng-Ming

机构信息

Clinical Medical College, Yangzhou University, Yangzhou, China.

出版信息

Front Oncol. 2022 Oct 14;12:983805. doi: 10.3389/fonc.2022.983805. eCollection 2022.

DOI:10.3389/fonc.2022.983805
PMID:36313635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9614063/
Abstract

OBJECTIVE

To explore the feasibility of single-point prostate biopsy in elderly patients with highly suspected prostate cancer.

METHODS

Forty-three patients with a prostate imaging reporting and data system score (PI-RADS) of 5, age ≥ 80 years and/or PSA ≥ 100 ng/ml and/or Eastern Cooperative Oncology Group score ≥ 2 were enrolled in our hospital from March 2020 to June 2022. Targeted surgery of these patients was performed using only precise local anesthesia in the biopsy area. The biopsy tissues were examined by intraoperative frozen section examination (IFSE). If the result of IFSE was negative, traditional systematic biopsy and further routine pathological examination were performed. The positive rate of biopsy, operation time, complications and pain score were recorded.

RESULTS

The positive rate of prostate biopsy was 94.7%. The results of IFSE in two patients were negative, and the routine pathological results of further systematic biopsy of those patients were also negative. The visual analog scale and visual numeric scale were 2 (2-4) and 3 (2-3), respectively, during the biopsy procedure. The mean time of operation was 8.5 ± 2.1 min from the beginning of anesthesia to the end of biopsy. It took 35.3 ± 18.7 minutes to obtain the pathological report of IFSE. The incidences of complication hematuria and urinary retention were 10.5% and 2.6%, respectively.

CONCLUSION

For elderly patients with highly suspected prostate cancer, single-point prostate biopsy can be used to quickly and safely obtain pathological results.

摘要

目的

探讨单点前列腺活检在高度怀疑前列腺癌的老年患者中的可行性。

方法

选取2020年3月至2022年6月在我院就诊的43例前列腺影像报告和数据系统(PI-RADS)评分为5分、年龄≥80岁和/或前列腺特异性抗原(PSA)≥100 ng/ml和/或东部肿瘤协作组(ECOG)评分≥2分的患者。仅在活检区域使用精确局部麻醉对这些患者进行靶向手术。活检组织通过术中冰冻切片检查(IFSE)。如果IFSE结果为阴性,则进行传统的系统活检和进一步的常规病理检查。记录活检阳性率、手术时间、并发症和疼痛评分。

结果

前列腺活检阳性率为94.7%。2例患者的IFSE结果为阴性,这些患者进一步系统活检的常规病理结果也为阴性。活检过程中视觉模拟量表(VAS)和视觉数字量表(VNS)评分分别为2(2-4)分和3(2-3)分。从麻醉开始到活检结束的平均手术时间为8.5±2.1分钟。获得IFSE病理报告需要35.3±18.7分钟。并发症血尿和尿潴留的发生率分别为10.5%和2.6%。

结论

对于高度怀疑前列腺癌的老年患者,单点前列腺活检可用于快速、安全地获得病理结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d4/9614063/9d7d85af39b8/fonc-12-983805-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d4/9614063/9d7d85af39b8/fonc-12-983805-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d4/9614063/9d7d85af39b8/fonc-12-983805-g001.jpg

相似文献

1
Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer.单点前列腺活检在高度怀疑前列腺癌老年患者中的应用。
Front Oncol. 2022 Oct 14;12:983805. doi: 10.3389/fonc.2022.983805. eCollection 2022.
2
The application of intraoperative frozen section examination in multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy during a major pandemic.术中冰冻切片检查在重大疫情期间多参数磁共振成像/经直肠超声融合前列腺活检中的应用
Quant Imaging Med Surg. 2022 Apr;12(4):2378-2384. doi: 10.21037/qims-21-473.
3
Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.前列腺影像报告和数据系统(PI-RADS)评分与前列腺特异性抗原(PSA)密度相结合可预测初次接受前列腺穿刺活检患者的活检结果。
BJU Int. 2017 Feb;119(2):225-233. doi: 10.1111/bju.13465. Epub 2016 Apr 1.
4
[Correlation analysis between prostate imaging report and data system score and pathological results of prostate cancer].[前列腺影像报告和数据系统评分与前列腺癌病理结果的相关性分析]
Zhonghua Yi Xue Za Zhi. 2020 Sep 15;100(34):2663-2668. doi: 10.3760/cma.j.cn112137-20200523-01626.
5
Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients.在未经活检和既往活检阴性的患者中,使用前列腺影像报告和数据系统评分及前列腺特异性抗原密度检测前列腺癌。
Prostate Int. 2020 Sep;8(3):125-129. doi: 10.1016/j.prnil.2020.03.003. Epub 2020 Apr 1.
6
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local Anesthesia.多参数磁共振成像在临床上用于检测前列腺癌:泌尿科医生需要知道的。第四部分:使用局部麻醉的经会阴磁共振-超声融合引导活检。
Eur Urol. 2022 Jan;81(1):110-117. doi: 10.1016/j.eururo.2021.10.032. Epub 2021 Nov 17.
7
Comparison of prostate cancer detection rates between magnetic resonance imaging-targeted biopsy and transrectal ultrasound-guided biopsy according to Prostate Imaging Reporting and Data System in patients with PSA ≥4 ng/mL: a systematic review and meta-analysis.根据前列腺影像报告和数据系统,对PSA≥4 ng/mL患者进行磁共振成像靶向活检与经直肠超声引导活检的前列腺癌检出率比较:一项系统评价和荟萃分析。
Transl Androl Urol. 2019 Dec;8(6):741-753. doi: 10.21037/tau.2019.12.03.
8
Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml?前列腺影像报告和数据系统第 2 版能否减少 PSA 水平在 4-10ng/ml 的男性进行不必要的前列腺活检?
J Cancer Res Clin Oncol. 2018 May;144(5):987-995. doi: 10.1007/s00432-018-2616-6. Epub 2018 Mar 5.
9
Who can safely evade a magnetic resonance imaging fusion-targeted biopsy (MRIFTB) for prostate imaging reporting and data system (PI-RADS) 3 lesion?哪些人可以安全地避免针对前列腺影像报告和数据系统(PI-RADS)3 级病变的磁共振成像融合靶向活检(MRIFTB)?
World J Urol. 2021 May;39(5):1463-1471. doi: 10.1007/s00345-020-03352-3. Epub 2020 Jul 21.
10
Diagnostic yields in patients with suspected prostate cancer undergoing MRI as the first-line investigation in routine practice.在常规实践中,对于疑似前列腺癌患者,行 MRI 作为一线检查,其诊断检出率。
Clin Radiol. 2020 Dec;75(12):950-956. doi: 10.1016/j.crad.2020.08.011. Epub 2020 Sep 9.

本文引用的文献

1
Role of Prophylactic Antibiotics in Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis.预防性抗生素在经会阴前列腺穿刺活检中的作用:一项系统评价和荟萃分析。
Eur Urol Open Sci. 2022 Jan 29;37:53-63. doi: 10.1016/j.euros.2022.01.001. eCollection 2022 Mar.
2
Application of 16 G Biopsy Needle in Transperineal Template-Guided Prostate Biopsy.16G 活检针在经会阴模板引导前列腺活检中的应用。
Urol Int. 2022;106(9):909-913. doi: 10.1159/000520373. Epub 2021 Dec 15.
3
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography.
多参数磁共振成像和前列腺特异性膜抗原正电子发射断层扫描后不进行前列腺活检的根治性前列腺切除术。
Eur Urol. 2022 Aug;82(2):156-160. doi: 10.1016/j.eururo.2021.11.019. Epub 2021 Dec 6.
4
Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort.对于接受磁共振成像检查的先前活检阴性的男性与活检初筛的男性相比,前列腺癌风险:PLUM 队列的前瞻性评估。
Cancer. 2022 Jan 1;128(1):75-84. doi: 10.1002/cncr.33875. Epub 2021 Aug 24.
5
Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy.基于经会阴模板引导前列腺活检的前列腺癌预测模型的建立与内部验证。
BMC Urol. 2021 Apr 23;21(1):68. doi: 10.1186/s12894-021-00840-5.
6
[Family-centered psychological support helps improve illness cognition and quality of life in patients with advanced prostate cancer].以家庭为中心的心理支持有助于改善晚期前列腺癌患者的疾病认知和生活质量。
Zhonghua Nan Ke Xue. 2020 Jun;26(6):505-512.
7
The application of a targeted periprostatic nerve block in transperineal template-guided prostate biopsies.靶向性前列腺周围神经阻滞在经会阴模板引导下前列腺活检中的应用
Quant Imaging Med Surg. 2020 Nov;10(11):2125-2132. doi: 10.21037/qims-20-369.
8
[Statistical analysis of incidence and mortality of prostate cancer in China, 2015].[2015年中国前列腺癌发病率与死亡率的统计分析]
Zhonghua Zhong Liu Za Zhi. 2020 Sep 23;42(9):718-722. doi: 10.3760/cma.j.cn112152-20200313-00200.
9
Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling.西地那非通过刺激 NO-cGMP 信号增强多西他赛在晚期前列腺癌中的治疗效果。
Clin Cancer Res. 2020 Nov 1;26(21):5720-5734. doi: 10.1158/1078-0432.CCR-20-1569. Epub 2020 Aug 26.
10
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.口服瑞戈非尼在晚期前列腺癌中的雄激素剥夺治疗。
N Engl J Med. 2020 Jun 4;382(23):2187-2196. doi: 10.1056/NEJMoa2004325. Epub 2020 May 29.